Postural Orthostatic Tachycardia Syndrome (POTS): Causes, Symptoms, Diagnosis, and Treatment

What is Postural Orthostatic Tachycardia Syndrome (POTS)?

Postural Orthostatic Tachycardia Syndrome (POTS) belongs to a broader group of disorders collectively known as orthostatic intolerance, conditions in which the body fails to adequately compensate for the effects of gravity on blood circulation when a person moves from a lying to a standing position.

What Happens When We Stand Up?

Under normal physiological conditions, the simple act of rising from a lying or seated position triggers a rapid and coordinated set of cardiovascular and neurological responses. Gravity causes approximately 750 mL of blood to shift downward, pooling in the abdomen, legs, and feet. To prevent a sudden drop in blood pressure and maintain adequate blood flow to the brain and heart, the body immediately responds by:

• Constricting peripheral blood vessels to increase vascular resistance
• Slightly increasing heart rate to maintain cardiac output
• Activating the renin-angiotensin-aldosterone system to retain fluid

All of these adjustments occur automatically and instantaneously, orchestrated by the autonomic nervous system, the division of the nervous system that governs involuntary bodily functions.

In individuals with POTS, this compensation is dysfunctional. The necessary adjustments in heart rate, blood pressure, and cerebral blood flow cannot be adequately produced due to abnormalities in the interactions between blood volume regulation, the cardiovascular system, and autonomic nervous control. The result is insufficient blood supply to the brain and heart, triggering a compensatory but excessive surge in heart rate.

Defining POTS

A key distinction must be made: POTS involves an abnormal increase in heart rate upon standing, known as orthostatic tachycardia, without a simultaneous significant drop in blood pressure (which would instead characterize orthostatic hypotension).

The diagnostic hallmark of POTS is:

• An increase in heart rate of ≥30 beats per minute (bpm) within 10 minutes of assuming an upright position (or ≥40 bpm in adolescents aged 12–19 years)
• Or a sustained heart rate exceeding 120 bpm upon standing
• In the absence of orthostatic hypotension (defined as a fall in systolic blood pressure ≥20 mmHg or diastolic ≥10 mmHg)

The cardinal symptom is dizziness or lightheadedness, and in some cases outright fainting (syncope), immediately upon standing. Symptoms are rapidly relieved by lying down again, which is one of the most characteristic and clinically useful features of the syndrome.

Who Is Affected?

POTS can affect individuals of any age, but the vast majority of patients (75–80%) are women between the ages of 15 and 50 years. Many female patients report a worsening of symptoms in the days immediately preceding menstrual flow, suggesting a hormonal influence on symptom severity.

The syndrome may onset following specific triggering events, including:

• Post-pregnancy (postpartum period)
• Major surgical procedures
• Physical trauma
• Viral illness, including COVID-19 (POTS has been increasingly recognized as a component of Long COVID or Post-COVID syndrome)

In its most severe forms, POTS can be significantly disabling, profoundly affecting a patient’s ability to work, study, and carry out daily activities. The syndrome typically follows a relapsing-remitting course, with symptoms that fluctuate over months or years. Encouragingly, the majority of patients (approximately 4 out of 5) experience some degree of improvement over time, though residual symptoms often persist.

---

Causes

The fundamental problem in POTS is a failure of the body’s normal compensatory mechanisms to adequately redistribute blood and maintain perfusion to the brain when moving to an upright position.

Normally, when you sit up or stand from a lying position, gravity draws blood downward. In response, blood vessels quickly constrict and heart rate increases modestly. All of this is coordinated by the autonomic nervous system to maintain adequate blood flow to the heart and brain without a drop in blood pressure.

In POTS patients, these mechanisms malfunction. The resulting reduction in cerebral and cardiac blood flow provokes a dramatic compensatory acceleration of the heart rate in an attempt to restore adequate perfusion. Why these mechanisms fail is still not fully understood, and in many patients no single definitive cause is identified (idiopathic POTS).

Known and Associated Causes

POTS is now understood to be a heterogeneous syndrome with multiple potential underlying mechanisms, which may co-exist in the same patient:

• Hypovolemia (reduced blood volume): Many POTS patients have a lower-than-normal total blood volume, which amplifies the hemodynamic challenge of standing. This may result from abnormal regulation of sodium and fluid retention.

• Peripheral denervation / autonomic neuropathy: In some patients, partial dysfunction of the autonomic nerves that control blood vessel constriction in the lower limbs (sympathetic adrenergic neuropathy) leads to excessive blood pooling upon standing.

• Hyperadrenergic state: A subset of patients have elevated norepinephrine (noradrenaline) levels when standing, driving excessive heart rate acceleration. This may be related to genetic mutations affecting norepinephrine transport or metabolism.

• Autoimmune mechanisms: Autoantibodies against autonomic receptors (particularly adrenergic and muscarinic receptors) have been identified in a proportion of POTS patients, suggesting an autoimmune component in some cases.

• Hypermobile Ehlers-Danlos Syndrome (hEDS): A heritable connective tissue disorder causing joint hypermobility and vascular fragility; POTS is highly prevalent in individuals with hEDS, possibly due to impaired vascular tone and excessive blood pooling.

• Autoimmune and inflammatory diseases: Including diabetes mellitus (autonomic neuropathy), amyloidosis, sarcoidosis, systemic lupus erythematosus, Sjögren’s syndrome, and paraneoplastic syndromes associated with cancer

• Toxic exposures: Alcohol intoxication or heavy metal poisoning may damage autonomic nerve function

• Post-infectious / post-viral POTS: Viral illnesses, including COVID-19 and previously documented influenza, Epstein-Barr virus, and other viral infections, are recognized triggers. This may occur through immune-mediated autonomic nerve damage or autoantibody production

• Deconditioning: Prolonged bed rest (e.g., following illness or surgery) leads to cardiovascular deconditioning that can precipitate or worsen POTS

POTS also frequently co-occurs with chronic fatigue syndrome / myalgic encephalomyelitis (ME/CFS), and the two conditions share significant clinical overlap.

Prevalence

POTS is estimated to affect between 0.2% and 1% of the population in developed countries, predominantly young, Caucasian women of reproductive age (15–45 years). Despite this, it remains significantly underdiagnosed, with many patients waiting years for a correct diagnosis. They are often told their symptoms are anxiety-related or psychosomatic.

---

Symptoms

The symptoms of POTS arise from the combined effects of insufficient blood flow to the brain (cerebral hypoperfusion) and the body’s excessive compensatory responses (particularly tachycardia and sympathetic activation). They may appear suddenly or gradually, immediately upon standing or within a few minutes, and are characteristically relieved or resolved by lying down.

Core Symptoms

• Dizziness, lightheadedness, or presyncope: The most common symptom; a sensation of spinning or “graying out” upon standing
• Syncope (fainting): Loss of consciousness; less common than presyncope but can occur in severe cases
• Palpitations: An uncomfortable awareness of a rapid or pounding heartbeat, which is the direct result of the compensatory tachycardia
• Brain fog: Cognitive difficulties, including impaired memory, concentration, and mental clarity, are among the most debilitating and frequently reported symptoms
• Fatigue and weakness: Profound, often disproportionate tiredness that is not relieved by rest
• Muscle weakness: Particularly in the legs

Accompanying Symptoms

• Tremors and excessive sweating (diaphoresis) are signs of heightened sympathetic nervous system activity
• Headache: often positional (worsened by standing)
• Sleep disturbances, including insomnia and non-restorative sleep
• Chest pain or discomfort
• Shortness of breath (dyspnea), particularly on exertion or when standing
• General malaise

Additional Manifestations

• Gastrointestinal symptoms: Nausea, abdominal pain, bloating, and altered bowel habits, reflecting autonomic dysfunction of the gut
• Bladder dysfunction: Urinary frequency or urgency
• Peripheral edema: Swelling of the feet and ankles due to blood pooling in the lower limbs
• Acrocyanosis: A characteristic bluish-purple discoloration of the skin at the ankles and feet, indicating venous blood pooling. This may be visually striking and diagnostically suggestive
• Hyperhidrosis: Sweaty or clammy skin, particularly of the hands and feet
• Joint hypermobility: Particularly in patients with co-existing hEDS
• Altered peripheral sensation: Numbness, tingling, or burning sensations in the extremities

Symptom Triggers and Aggravating Factors

Certain conditions are known to worsen POTS symptoms:

• Warm environments or hot weather (heat causes vasodilation and further blood pooling)
• Large meals (postprandial blood pooling in the gut diverts blood from the systemic circulation)
• Strenuous exercise, though structured and graduated exercise is ultimately beneficial
• Menstruation in female patients
• Dehydration and alcohol consumption
• Prolonged standing
• Illness or infection

---

Diagnosis

POTS should be suspected in patients with multiple chronic symptoms, particularly chronic fatigue, recurrent dizziness upon standing, palpitations, cognitive impairment, and occasional syncope. This is especially true when symptoms are consistently triggered or worsened by postural change.

Diagnostic Criteria

The current consensus diagnostic criteria for POTS in adults require:

1. An increase in heart rate of ≥30 bpm (or reaching ≥120 bpm) within 10 minutes of assuming an upright posture
2. Absence of orthostatic hypotension (i.e., no drop in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg)
3. Symptoms of orthostatic intolerance present for ≥3 months

In adolescents (aged 12–19), the threshold is ≥40 bpm increase.

Diagnostic Tests

Tilt Table Test (Head-Up Tilt Test)

The tilt table test is the gold standard for diagnosing POTS. The patient lies on a motorized table that is slowly tilted to an upright position (typically 60–80°). Heart rate and blood pressure are continuously monitored throughout the test. This controlled environment allows precise, reproducible measurement of the orthostatic cardiovascular response.

Active Stand Test (Bedside Assessment)

A simpler alternative for clinical or ambulatory settings: heart rate and blood pressure are measured after lying supine, then at regular intervals after standing (immediately, at 2, 5, and 10 minutes). While less precise than the tilt table test, it is a practical first-line assessment tool.

Additional Investigations

To rule out secondary causes and assess overall cardiovascular and metabolic health, the following are typically also requested:

• Blood tests: full blood count (CBC), thyroid function tests, renal function, liver function, electrolytes, fasting glucose, and inflammatory markers
• Electrocardiogram (ECG): to exclude primary cardiac arrhythmias
• Echocardiogram: to assess cardiac structure and function
• 24-hour ambulatory blood pressure monitoring (Holter monitor): to capture blood pressure and heart rate fluctuations across daily activities
• Plasma norepinephrine levels (standing vs. supine): elevated standing norepinephrine (>600 pg/mL) supports the hyperadrenergic subtype
• Autoimmune antibody panel: in appropriate clinical contexts (antinuclear antibodies, anti-adrenergic receptor antibodies)
• Skin punch biopsy for intraepidermal nerve fiber density: to evaluate for small fiber neuropathy

Differential Diagnosis

POTS shares symptoms with many other conditions, making differential diagnosis essential. Conditions to exclude include:

• Orthostatic hypotension: distinguished by the presence of a significant blood pressure drop upon standing
• Anxiety disorders and panic attacks: POTS is frequently and unfortunately misdiagnosed as anxiety. A key differentiator is that POTS symptoms are reliably orthostatic (position-dependent), whereas anxiety symptoms are not
• Primary cardiac arrhythmias: distinguished by ECG and cardiac monitoring
• Medication side effects: many drugs can cause orthostatic tachycardia or hypotension (e.g., diuretics, vasodilators, antidepressants)
• Hypotension from other causes
• Dehydration and anemia
• Endocrine disorders: hyperthyroidism, adrenal insufficiency, pheochromocytoma
• Chronic fatigue syndrome / ME-CFS (frequently co-exists with POTS rather than being a true alternative diagnosis)

---

Treatment

There is currently no single universally effective cure for POTS. Management is individualized and typically involves a combination of non-pharmacological strategies and, where necessary, pharmacological support. For most patients, significant improvement can be achieved through lifestyle modifications alone.

Immediate Management of an Episode

When symptoms occur upon standing, the following physical counterpressure maneuvers can rapidly restore blood pressure and reduce heart rate:

• Lie down immediately and, if possible, elevate the legs above heart level. This rapidly redistributes blood back to the central circulation and brain
• If lying down is not possible: cross your legs in front of each other while standing, rise up and down on tiptoes, and tighten the gluteal and abdominal muscles. All of these activate the muscle pump, promoting venous return and constricting blood vessels
• Clench your fists to activate the arm muscle pump

Lifestyle and Non-Pharmacological Strategies

The following measures form the foundation of POTS management and are recommended for all patients:

• Generous fluid intake: Aim for 2–3 liters of water per day to maintain adequate blood volume. A bolus of 500 mL of cold water has been shown to acutely increase blood pressure and reduce heart rate for 1–2 hours.

• Increased salt intake: A high-sodium diet (10–12 g of sodium chloride per day) helps retain fluid and expand blood volume, but only if specifically advised by your physician, as this is contraindicated in patients with hypertension, heart failure, or kidney disease.

• Graduated compression stockings: Waist-high or thigh-high compression garments (20–40 mmHg) reduce venous pooling in the lower limbs and can significantly reduce orthostatic heart rate acceleration. Abdominal binders may provide additional benefit.

• Structured, progressive exercise: Physical reconditioning is one of the most evidence-based interventions for POTS. Research demonstrates that a gradually progressive exercise program, which initially focuses on recumbent or semi-recumbent activities such as swimming, rowing, or recumbent cycling to minimize orthostatic stress, can produce lasting improvements in symptoms and cardiovascular function. Over time, upright exercise (walking, running, pilates, resistance training of the lower limbs) is progressively introduced. Exercise should be performed gradually and, initially, under supervision, as it may temporarily worsen symptoms.

• Elevate the head of the bed: Sleeping with the bed head raised by 10–20 cm (4–8 inches) reduces nocturnal fluid shifts to the legs and helps the body adapt to orthostatic stress.

• Postural awareness: Rise slowly from lying to sitting. Then, move from sitting to standing. Pause at each stage for 1 to 2 minutes; this allows your cardiovascular system to adapt before you proceed.

• Avoid prolonged standing: If standing is unavoidable, shift weight regularly between feet and employ counterpressure maneuvers.

• Avoid triggers: Limit caffeine and alcohol consumption; avoid overheating (hot showers, saunas, hot weather); eat small, frequent meals rather than large ones.

Pharmacological Treatment

There are currently no medications specifically approved for POTS. However, several drugs targeting the underlying hemodynamic abnormalities may be prescribed off-label:

The choice of pharmacological agent is individualized based on the patient’s POTS subtype, symptom profile, comorbidities, and response to lifestyle measures. A specialist in cardiology, autonomic medicine, or neurology should guide pharmacological management.

Treating Underlying Conditions

When POTS is secondary to an identifiable cause (e.g., autoimmune disease, hypothyroidism, anemia, nutritional deficiency), treating the underlying condition is a fundamental part of management and may significantly reduce POTS symptoms.

Prognosis

The prognosis of POTS varies. In adolescents and young adults, spontaneous improvement is relatively common over several years. Sometimes, this even leads to complete resolution, especially when lifestyle measures are consistently followed and appropriate management is in place. In adults, the course is often more chronic and relapsing-remitting. With optimal management, the majority of patients (approximately 80%) experience meaningful improvement in symptoms and quality of life, though complete remission is less common.

---

Sources and Bibliography

• National Institute of Neurological Disorders and Stroke (NIH/NINDS): Postural Tachycardia Syndrome (POTS)
• Postural Orthostatic Tachycardia Syndrome: Sean Zhao; Vu H. Tran. StatPearls, NCBI/NIH
• NHS: Postural Tachycardia Syndrome (POTS)
• Sheldon RS et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. 2015;12(6):e41-63. PubMed
• Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018;215:20-27.
• Raj SR. The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management. Indian Pacing Electrophysiol J. 2006;6(2):84-99. PubMed
• Bryarly M et al. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019;73(10):1207-1228. PubMed
• Dysautonomia International: POTS
• Mayo Clinic: Postural Tachycardia Syndrome (POTS)